The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hereditary Angioedema Market Research Report 2025

Global Hereditary Angioedema Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903930

No of Pages : 79

Ask Your Query

Synopsis

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

The global Hereditary Angioedema market was valued at US$ 1656.7 million in 2023 and is anticipated to reach US$ 2724.1 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema.

Report Scope

The Hereditary Angioedema market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Angioedema market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hereditary Angioedema manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Market Segmentation

By Company

  • Pharming Group NV
  • Takeda
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.

Segment by Type

  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist

Segment by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Hereditary Angioedema Market Overview
1.1 Product Overview and Scope of Hereditary Angioedema
1.2 Hereditary Angioedema Segment by Type
1.2.1 Global Hereditary Angioedema Market Value Comparison by Type (2024-2030)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Segment by Distribution Channel
1.3.1 Global Hereditary Angioedema Market Value by Distribution Channel: (2024-2030)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Market Size Estimates and Forecasts
1.4.1 Global Hereditary Angioedema Revenue 2019-2030
1.4.2 Global Hereditary Angioedema Sales 2019-2030
1.4.3 Global Hereditary Angioedema Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hereditary Angioedema Market Competition by Manufacturers
2.1 Global Hereditary Angioedema Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hereditary Angioedema Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hereditary Angioedema Average Price by Manufacturers (2019-2024)
2.4 Global Hereditary Angioedema Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hereditary Angioedema, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hereditary Angioedema, Product Type & Application
2.7 Hereditary Angioedema Market Competitive Situation and Trends
2.7.1 Hereditary Angioedema Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hereditary Angioedema Players Market Share by Revenue
2.7.3 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hereditary Angioedema Retrospective Market Scenario by Region
3.1 Global Hereditary Angioedema Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hereditary Angioedema Global Hereditary Angioedema Sales by Region: 2019-2030
3.2.1 Global Hereditary Angioedema Sales by Region: 2019-2024
3.2.2 Global Hereditary Angioedema Sales by Region: 2025-2030
3.3 Global Hereditary Angioedema Global Hereditary Angioedema Revenue by Region: 2019-2030
3.3.1 Global Hereditary Angioedema Revenue by Region: 2019-2024
3.3.2 Global Hereditary Angioedema Revenue by Region: 2025-2030
3.4 North America Hereditary Angioedema Market Facts & Figures by Country
3.4.1 North America Hereditary Angioedema Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hereditary Angioedema Sales by Country (2019-2030)
3.4.3 North America Hereditary Angioedema Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hereditary Angioedema Market Facts & Figures by Country
3.5.1 Europe Hereditary Angioedema Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hereditary Angioedema Sales by Country (2019-2030)
3.5.3 Europe Hereditary Angioedema Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hereditary Angioedema Market Facts & Figures by Country
3.6.1 Asia Pacific Hereditary Angioedema Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hereditary Angioedema Sales by Country (2019-2030)
3.6.3 Asia Pacific Hereditary Angioedema Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hereditary Angioedema Market Facts & Figures by Country
3.7.1 Latin America Hereditary Angioedema Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hereditary Angioedema Sales by Country (2019-2030)
3.7.3 Latin America Hereditary Angioedema Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hereditary Angioedema Market Facts & Figures by Country
3.8.1 Middle East and Africa Hereditary Angioedema Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hereditary Angioedema Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hereditary Angioedema Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hereditary Angioedema Sales by Type (2019-2030)
4.1.1 Global Hereditary Angioedema Sales by Type (2019-2024)
4.1.2 Global Hereditary Angioedema Sales by Type (2025-2030)
4.1.3 Global Hereditary Angioedema Sales Market Share by Type (2019-2030)
4.2 Global Hereditary Angioedema Revenue by Type (2019-2030)
4.2.1 Global Hereditary Angioedema Revenue by Type (2019-2024)
4.2.2 Global Hereditary Angioedema Revenue by Type (2025-2030)
4.2.3 Global Hereditary Angioedema Revenue Market Share by Type (2019-2030)
4.3 Global Hereditary Angioedema Price by Type (2019-2030)
5 Segment by Distribution Channel
5.1 Global Hereditary Angioedema Sales by Distribution Channel (2019-2030)
5.1.1 Global Hereditary Angioedema Sales by Distribution Channel (2019-2024)
5.1.2 Global Hereditary Angioedema Sales by Distribution Channel (2025-2030)
5.1.3 Global Hereditary Angioedema Sales Market Share by Distribution Channel (2019-2030)
5.2 Global Hereditary Angioedema Revenue by Distribution Channel (2019-2030)
5.2.1 Global Hereditary Angioedema Revenue by Distribution Channel (2019-2024)
5.2.2 Global Hereditary Angioedema Revenue by Distribution Channel (2025-2030)
5.2.3 Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2019-2030)
5.3 Global Hereditary Angioedema Price by Distribution Channel (2019-2030)
6 Key Companies Profiled
6.1 Pharming Group NV
6.1.1 Pharming Group NV Corporation Information
6.1.2 Pharming Group NV Description and Business Overview
6.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pharming Group NV Hereditary Angioedema Product Portfolio
6.1.5 Pharming Group NV Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Hereditary Angioedema Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 CSL Limited
6.3.1 CSL Limited Corporation Information
6.3.2 CSL Limited Description and Business Overview
6.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Limited Hereditary Angioedema Product Portfolio
6.3.5 CSL Limited Recent Developments/Updates
6.4 iBio Inc.
6.4.1 iBio Inc. Corporation Information
6.4.2 iBio Inc. Description and Business Overview
6.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2019-2024)
6.4.4 iBio Inc. Hereditary Angioedema Product Portfolio
6.4.5 iBio Inc. Recent Developments/Updates
6.5 BioCryst Pharmaceuticals, Inc.
6.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
6.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview
6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolio
6.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Ionis Pharmaceuticals, Inc.
6.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
6.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolio
6.6.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hereditary Angioedema Industry Chain Analysis
7.2 Hereditary Angioedema Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hereditary Angioedema Production Mode & Process
7.4 Hereditary Angioedema Sales and Marketing
7.4.1 Hereditary Angioedema Sales Channels
7.4.2 Hereditary Angioedema Distributors
7.5 Hereditary Angioedema Customers
8 Hereditary Angioedema Market Dynamics
8.1 Hereditary Angioedema Industry Trends
8.2 Hereditary Angioedema Market Drivers
8.3 Hereditary Angioedema Market Challenges
8.4 Hereditary Angioedema Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock